Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
NCT07090161
This study is recruiting at 18 US sites in 13 states, according to its ClinicalTrials.gov record last updated .
Summary
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Iloperidone for the Treatment of Participants with Uncontrolled Hypertension
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Hypertension
- Uncontrolled Hypertension
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 2
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Vanda Pharmaceuticals
- Last updated on ClinicalTrials.gov
- February 27, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Arizona · 1
- Vanda Investigative Site · Tempe, AZ
California · 3
- Vanda Investigative Site · Chula Vista, CA
- Vanda Investigative Site · Dublin, CA
- Vanda Investigative Site · Walnut Creek, CA
Florida · 1
- Vanda Investigative Site · Fort Myers, FL
Georgia · 1
- Vanda Investigative Site · Columbus, GA
Illinois · 2
- Vanda Investigative Site · Oak Brook, IL
- Vanda Investigative Site · Tinley Park, IL
Kansas · 2
- Vanda Investigative Site · El Dorado, KS
- Vanda Investigative Site · Wichita, KS
Kentucky · 1
- Vanda Investigative Site · Lexington, KY
Missouri · 1
- Vanda Investigative Site · Hazelwood, MO
North Carolina · 1
- Vanda Investigative Site · Kinston, NC
Ohio · 1
- Vanda Investigative Site · Cincinnati, OH
Oklahoma · 1
- Vanda Investigative Site · Norman, OK
South Carolina · 1
- Vanda Investigative Site · Charleston, SC
Virginia · 2
- Vanda Investigative Site · Burke, VA
- Vanda Investigative Site · Norfolk, VA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.